Welcome to Natrecor360.com
Welcome to Natrecor360.com
NATRECOR® (nesiritide) is indicated for the intravenous treatment of patients with acutely decompensated congestive heart failure who have dyspnea (shortness of breath) at rest or with minimal activity. In this population, the use of NATRECOR® reduced pulmonary capillary wedge pressure (PCWP) and improved dyspnea.
This site is intended for US healthcare professionals.
© Scios Inc. 2009-2012.